Your browser doesn't support javascript.
loading
Selective somatostatin receptor 5 inhibition improves hepatic insulin sensitivity.
Tamura, Yumiko Okano; Sugama, Jun; Abe, Shin-Ichi; Shimizu, Yuji; Hirose, Hideki; Watanabe, Masanori.
Afiliação
  • Tamura YO; Cardiovascular and Metabolic Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.
  • Sugama J; Cardiovascular and Metabolic Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.
  • Abe SI; Cardiovascular and Metabolic Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.
  • Shimizu Y; Biomolecular Research Laboratories, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.
  • Hirose H; Cardiovascular and Metabolic Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.
  • Watanabe M; Cardiovascular and Metabolic Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.
Pharmacol Res Perspect ; 11(1): e01043, 2023 02.
Article em En | MEDLINE | ID: mdl-36585794
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2023 Tipo de documento: Article